Interesting read ... https://cardiex.com/assessing-cardiovascular-risk-in-the-face-of-covid-19/
"The gold standard for non-invasive central blood pressure and arterial stiffness measurement is ATCOR’s SphygmoCor® XCEL. ATCOR technology equips healthcare providers with vital insights into their patients’ vascular health—including but not limited to arterial stiffness, pulse wave reflections, and central aortic blood pressure. This information will be critical as we move forward in our understanding, prevention, and treatment of individuals with COVID-19."
IMO highlights the huge potential of CDX's product uptake when they roll out their range of new, 'telemedicine ready' cardiovascular monitoring devices, based on ATCOR's Sphygmocor technology.
GLTA Holders
Interesting read ......
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $15.88M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.5¢ | 5.2¢ | $31.07K | 586.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 149188 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.4¢ | 5.3¢ | 56887 | ||
| Last updated 11.47am 03/05/2024 ? | |||||
| CDX (ASX) Chart |